Prevalence & Profile of Aspirin Resistance in Hemodialysis Patients

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients

We will try to describe the profile of aspirin resistant patient in hemodialysis patients ;

Observational Model: Case Control, Time Perspective: Cross-Sectional

See also
Status	Clinical Trial	Phase
Completed	`NCT01432652` - The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery	N/A
Completed	`NCT00948987` - Mechanism Based Resistance to Aspirin	Phase 1
Unknown status	`NCT01935193` - Aspirin Resistance Reversibility in Diabetic Patients	Phase 4
Not yet recruiting	`NCT01547039` - Platelet Reactivity and MES During CEA	N/A
Completed	`NCT01159639` - Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting	Phase 4
Completed	`NCT00466154` - The Effect of Serum LDL Lowering on Aspirin Resistance	N/A
Completed	`NCT01104441` - Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia